News
Thank you for supporting NET research in 2019
Thank you for supporting NET research in 2019 Together we can fund research needed to find a cure for neuroendocrine cancer The 2019 results are
NETRF Awards $3.5 Million in Grants
Research to Advance Neuroendocrine Tumor Treatment The Neuroendocrine Tumor Research Foundation (NETRF) today announced $3.5 million in neuroendocrine tumor (NET) research grants to fund 12
Exploring new ground with a clinical trial of a NET cancer vaccine
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.
Celebrating the Next Chapter
After chemotherapy for pancreatic NET, Chef Jack Riebel embraces life with new optimism, doing what he enjoys most, and finding meaning by giving back.
Spirituality and Cancer
Many people with neuroendocrine cancer look more deeply for meaning in their lives. They want to understand their purpose in life or why they got cancer.
COMPETE Clinical Trial
A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,
Coping with Loss During the Holidays
Following the loss of a loved one, holiday traditions may be more painful than joyful. Many things can trigger memories that seem to amplify your
A Look at Lung NETs
Approximately 20% of all primary lung tumors are neuroendocrine (Hung 2019), including: Typical carcinoid (TC) Atypical carcinoid (AC) Small cell carcinoma (SCC) Large cell carcinoma
Retrospective Art Show Benefits NETRF
The late Carl Schaad captured on canvas the beauty of New England and Italy, with expansive landscapes and small still life. Family and friends gathered
NETRF-funded Research Included Among 2019’s Most Important Developments
Highlights from NANETS 2019 symposium where leading NET experts presented progress and identified priorities for moving NET knowledge and care forward.